Literature DB >> 28456895

Cannabis Use, Medication Management and Adherence Among Persons Living with HIV.

Denise C Vidot1, Brenda Lerner2, Raul Gonzalez2.   

Abstract

Cannabis is used to relieve nausea, trigger weight gain, and reduce pain among adults living with HIV; however, the relationship between its use and medication adherence and management is unclear. Participants (N = 107) were from an ongoing cohort study of community-dwelling HIV+ adults, stratified by cannabis (CB) use: HIV+/CB+ (n = 41) and HIV+/CB- (n = 66). CB+ participants either tested positive in a urine toxicology screen for THC or had a self-reported history of regular and recent use. HIV-status was provided by physician results and/or biomarker assessment. Adherence was measured via the Morisky scale and medication management was assessed via the Medication Management Test-Revised. After adjusting for gender, we found no association between cannabis use group and adherence nor medication management. The amount of cannabis used was also not associated with measures of adherence and management. Preliminary findings suggest that cannabis use may not adversely influence medication adherence/management among adults living with HIV.

Entities:  

Keywords:  Adherence; Cannabis; HIV; Medication management

Mesh:

Substances:

Year:  2017        PMID: 28456895      PMCID: PMC5503453          DOI: 10.1007/s10461-017-1782-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  41 in total

Review 1.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

2.  Drug use and medication adherence among HIV-1 infected individuals.

Authors:  Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore
Journal:  AIDS Behav       Date:  2007-03

3.  Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence.

Authors:  Magdalena Cerdá; Melanie Wall; Katherine M Keyes; Sandro Galea; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2011-11-17       Impact factor: 4.492

Review 4.  The pharmacologic and clinical effects of medical cannabis.

Authors:  Laura M Borgelt; Kari L Franson; Abraham M Nussbaum; George S Wang
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

5.  Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.

Authors:  Adam Gonzalez; Matthew J Mimiaga; Jared Israel; C Andres Bedoya; Steven A Safren
Journal:  AIDS Behav       Date:  2013-01

6.  High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.

Authors:  Gregory Slawson; M-J Milloy; Lynda Balneaves; Annick Simo; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood; Thomas Kerr
Journal:  AIDS Behav       Date:  2015-01

7.  Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort.

Authors:  Matthew J Mimiaga; Sari L Reisner; Chris Grasso; Heidi M Crane; Steven A Safren; Mari M Kitahata; Joseph E Schumacher; W Christopher Mathews; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

Review 8.  Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance.

Authors:  Raul Gonzalez
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

9.  Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep.

Authors:  Margaret Haney; Erik W Gunderson; Judith Rabkin; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Richard W Foltin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-15       Impact factor: 3.731

10.  Neurocognitive functioning in acute or early HIV infection.

Authors:  David J Moore; Scott L Letendre; Sheldon Morris; Anya Umlauf; Reena Deutsch; Davey M Smith; Susan Little; Alexandra Rooney; Donald R Franklin; Ben Gouaux; Shannon Leblanc; Debra Rosario; Christine Fennema-Notestine; Robert K Heaton; Ronald J Ellis; J Hampton Atkinson; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-15       Impact factor: 2.643

View more
  13 in total

1.  The Association Between Marijuana Use and HIV Continuum of Care Outcomes: a Systematic Review.

Authors:  LaTrice Montgomery; Kara Bagot; Jennifer L Brown; Angela M Haeny
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

Review 2.  Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Authors:  M Eugenia Socias; M-J Milloy
Journal:  Curr Infect Dis Rep       Date:  2018-07-31       Impact factor: 3.725

3.  Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV.

Authors:  Chukwuemeka N Okafor; Michael W Plankey; David Goodman-Meza; Michael Li; Karla J Bautista; Hector Bolivar; Tien C Phyllis; Todd T Brown; Steven J Shoptaw
Journal:  Drug Alcohol Depend       Date:  2020-02-20       Impact factor: 4.492

4.  Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic Pain.

Authors:  Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopolous; Kasey R Claborn; Heidi M Crane; Eva Jennifer Edelman; Travis I Lovejoy; William Christopher Mathews; Benjamin J Morasco; Sonia Napravnik; Connall OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross; Jane M Liebschutz
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

5.  The Relationships Among Social Capital, HIV Self-Management, and Substance Use in Women.

Authors:  Allison R Webel; Carolyn Smith; Joseph Perazzo; J Craig Phillips; Hamed Al Battashi; Carol Dawson-Rose
Journal:  West J Nurs Res       Date:  2019-04-21       Impact factor: 1.967

6.  A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.

Authors:  Sebastian Jugl; Aimalohi Okpeku; Brianna Costales; Earl J Morris; Golnoosh Alipour-Haris; Juan M Hincapie-Castillo; Nichole E Stetten; Ruba Sajdeya; Shailina Keshwani; Verlin Joseph; Yahan Zhang; Yun Shen; Lauren Adkins; Almut G Winterstein; Amie Goodin
Journal:  Med Cannabis Cannabinoids       Date:  2021-02-25

7.  Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes.

Authors:  Vinay Kumar; Workineh Torben; Joshua Mansfield; Xavier Alvarez; Curtis Vande Stouwe; Jian Li; Siddappa N Byrareddy; Peter J Didier; Bapi Pahar; Patricia E Molina; Mahesh Mohan
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

8.  Long-Term Low-Dose Delta-9-Tetrahydrocannbinol (THC) Administration to Simian Immunodeficiency Virus (SIV) Infected Rhesus Macaques Stimulates the Release of Bioactive Blood Extracellular Vesicles (EVs) that Induce Divergent Structural Adaptations and Signaling Cues.

Authors:  Yuan Lyu; Steven Kopcho; Mahesh Mohan; Chioma M Okeoma
Journal:  Cells       Date:  2020-10-06       Impact factor: 6.600

9.  HIV infection is linked with reduced error-related default mode network suppression and poorer medication management abilities.

Authors:  Jessica S Flannery; Michael C Riedel; Taylor Salo; Ranjita Poudel; Angela R Laird; Raul Gonzalez; Matthew T Sutherland
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-07-03       Impact factor: 5.067

10.  Microstructural brain abnormalities in HIV+ individuals with or without chronic marijuana use.

Authors:  Hannah A Wang; Hua-Jun Liang; Thomas M Ernst; Kenichi Oishi; Linda Chang
Journal:  J Neuroinflammation       Date:  2020-08-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.